Clinical Trial

The MELAcare Study: A New Method for Surveillance of Melanoma Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2023 (before its estimated June 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate a new method of follow-up for patients with low and intermediate risk (stages IA-IIA) melanoma. The investigators will compare different tools for patient support and education combined with clinician supported skin self-examination (SSE) to the current standard-of-care. The hypothesis is that meta-cognitive strategies and clinician supported SSE can lower fear of cancer recurrence (FCR) and promote effective SSE on a regular basis without compromising the detection of new primary melanomas and/or metastases.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-14; most recent amendment 2023-06-23.
Status change: Not Yet Recruiting → Recruiting 2022-03-11
Trial Details
NCT Number NCT05253872
Lead Sponsor Herlev and Gentofte Hospital
Collaborators: Danish Cancer Society
Conditions Cutaneous Melanoma
Enrollment 378 participants
Start Date 2022-03-09
Primary Completion 2024-06 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2023-06-26